{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:22:49Z","timestamp":1791037369407,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1053\/j.seminoncol.2011.11.004","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T18:52:02Z","timestamp":1327949522000},"page":"67-73","source":"Crossref","is-referenced-by-count":39,"title":["Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: Novel Pathogenetic Lesions"],"prefix":"10.1053","volume":"39","author":[{"given":"Hideki","family":"Muramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2011.11.004_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","article-title":"The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia","volume":"87","author":"Bennett","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa020150","article-title":"Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta","volume":"347","author":"Apperley","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1008393002748","article-title":"Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia","volume":"11","author":"Hernandez","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V78.1.205.205","article-title":"Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia","volume":"78","author":"Martiat","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/10428199709114162","article-title":"Clinical and biological aspects of Philadelphia-negative\/BCR-negative chronic myeloid leukemia","volume":"25","author":"Costello","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib7","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2010-10-311019","article-title":"Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A","volume":"118","author":"Jankowska","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib8","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1371\/journal.pone.0001225","article-title":"SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS\/MPD-U and MPD","volume":"2","author":"Gondek","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/dna.2007.0675","article-title":"Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma","volume":"27","author":"Turner","year":"2008","journal-title":"DNA Cell Biol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.leukres.2004.10.001","article-title":"Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"29","author":"Loh","year":"2005","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.leu.2403492","article-title":"PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group","volume":"18","author":"Loh","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2009-06-226340","article-title":"Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia","volume":"115","author":"Muramatsu","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib13","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood-2009-01-198416","article-title":"Mutations in CBL occur frequently in juvenile myelomonocytic leukemia","volume":"114","author":"Loh","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib14","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V83.8.2248.2248","article-title":"Mutations of the N-ras gene in juvenile chronic myelogenous leukemia","volume":"83","author":"Miyauchi","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0145-2126(97)00036-2","article-title":"Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia","volume":"21","author":"Sheng","year":"1997","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.leu.2401240","article-title":"RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)","volume":"13","author":"Flotho","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2010.08196.x","article-title":"Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations","volume":"150","author":"Sugimoto","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2010.08393.x","article-title":"Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia","volume":"151","author":"Perez","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms","volume":"460","author":"Sanada","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib20","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1200\/JCO.2009.23.7503","article-title":"Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies","volume":"27","author":"Makishima","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib21","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib22","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1182\/blood-2008-12-194548","article-title":"Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms","volume":"113","author":"Grand","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib23","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood.V66.6.1371.1371","article-title":"Transforming genes in human leukemia cells","volume":"66","author":"Hirai","year":"1985","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V76.6.1214.1214","article-title":"RAS mutations are rare events in Philadelphia chromosome-negative\/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia","volume":"76","author":"Hirsch-Ginsberg","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib26","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-09-2112","article-title":"RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant","volume":"16","author":"Ricci","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/leu.2009.48","article-title":"RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation","volume":"23","author":"Kuo","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib28","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.2009.065904","article-title":"JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia","volume":"62","author":"Pich","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib31","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib32","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib33","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","article-title":"Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms","volume":"113","author":"Jankowska","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib34","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib35","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1200\/JCO.2009.22.6985","article-title":"Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome","volume":"27","author":"Mohamedali","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/leu.2010.167","article-title":"Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies","volume":"24","author":"Makishima","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature09586","article-title":"Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","article-title":"Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib44","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3324\/haematol.2009.011205","article-title":"TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia","volume":"94","author":"Kosmider","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1074\/jbc.M109.065862","article-title":"ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib47","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib48","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations","volume":"207","author":"Gross","year":"2010","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib52","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J. Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib53","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2009-11-253070","article-title":"Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation","volume":"115","author":"Chou","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMc0910063","article-title":"Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms","volume":"362","author":"Green","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2141.2006.06081.x","article-title":"C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders","volume":"133","author":"Caudill","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.leu.2402805","article-title":"The emergence of a C\/EBPalpha mutation in the clonal evolution of MDS towards secondary AML","volume":"17","author":"Kaeferstein","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2011.232","article-title":"SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts","author":"Visconte","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","author":"Graubert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib60","unstructured":"Makishima H, Visconte V, Sakaguchi H, et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood. (submitted)."},{"key":"10.1053\/j.seminoncol.2011.11.004_bib61","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.004_bib62","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411002934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411002934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T17:24:57Z","timestamp":1713461097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775411002934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0093775411002934"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2011.11.004","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}